Dr. Nonyem A. Onujiogu
Claim this profileMemorial Hospital of South Bend
Studies Adenocarcinoma
Studies Serous Cystadenocarcinoma
7 reported clinical trials
21 drugs studied
Area of expertise
1Adenocarcinoma
Stage IV
Stage II
Stage III
2Serous Cystadenocarcinoma
Stage IV
Stage II
Stage III
Affiliated Hospitals
Clinical Trials Nonyem A. Onujiogu is currently running
Ipatasertib + Megestrol Acetate
for Endometrial Cancer
This trial is testing if combining two drugs, ipatasertib and megestrol acetate, is more effective than using megestrol acetate alone for treating women with endometrial cancer that has returned or spread. Ipatasertib blocks enzymes needed for cancer cell growth, while megestrol acetate reduces and blocks estrogen, which some cancer cells need to grow.
Recruiting1 award Phase 1 & 2
Letrozole +/- Chemotherapy
for Ovarian Cancer
This phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum. Letrozole is an enzyme inhibitor that lowers the amount of estrogen made by the body which in turn may stop the growth of tumor cells that need estrogen to grow. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving letrozole alone or in combination with paclitaxel and carboplatin works better in treating patients with low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum compared to paclitaxel and carboplatin without letrozole.
Recruiting2 awards Phase 318 criteria
More about Nonyem A. Onujiogu
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Nonyem A. Onujiogu has experience with
- Olaparib
- Cediranib Maleate
- Durvalumab
- Letrozole
- Paclitaxel, Carboplatin
- Cisplatin
Breakdown of trials Nonyem A. Onujiogu has run
Adenocarcinoma
Serous Cystadenocarcinoma
Cancer
Endometrioid Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nonyem A. Onujiogu specialize in?
Nonyem A. Onujiogu focuses on Adenocarcinoma and Serous Cystadenocarcinoma. In particular, much of their work with Adenocarcinoma has involved Stage IV patients, or patients who are Stage II.
Is Nonyem A. Onujiogu currently recruiting for clinical trials?
Yes, Nonyem A. Onujiogu is currently recruiting for 3 clinical trials in South Bend Indiana. If you're interested in participating, you should apply.
Are there any treatments that Nonyem A. Onujiogu has studied deeply?
Yes, Nonyem A. Onujiogu has studied treatments such as Olaparib, Cediranib Maleate, Durvalumab.
What is the best way to schedule an appointment with Nonyem A. Onujiogu?
Apply for one of the trials that Nonyem A. Onujiogu is conducting.
What is the office address of Nonyem A. Onujiogu?
The office of Nonyem A. Onujiogu is located at: Memorial Hospital of South Bend, South Bend, Indiana 46601 United States. This is the address for their practice at the Memorial Hospital of South Bend.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.